New Directions in the Treatment of Patients With Chronic Myeloid LeukemiaBACCARANI, Michele.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, 35 p., SUP3Serial Issue

New Directions in the Treatment of Imatinib Failure and/or ResistanceGILES, Francis J.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S27-S33, SUP3Article

Optimizing First-Line Therapy for Patients With Chronic Myeloid LeukemiaFAVA, Carmen; CORTES, Jorge.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S5-S10, SUP3Article

Interferon-alfa for chronic myeloid leukemiaBACCARANI, Michele; RUSSO, Domenico; ROSTI, Gianantonio et al.Seminars in hematology. 2003, Vol 40, Num 1, pp 22-33, issn 0037-1963, 12 p.Article

Practical Considerations for the Management of Patients in the Tyrosine Kinase Inhibitor EraO'DWYER, Michael; ATALLAH, Ehab.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S16-S21, SUP3Article

Clinical Strategies to Achieve an Early and Successful Response to Tyrosine Kinase Inhibitor TherapyHUGHES, Timothy; HOCHHAUS, Andreas.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S11-S15, SUP3Article

Understanding the Role of Mutations in Therapeutic Decision Making for Chronic Myeloid LeukemiaJABBOUR, Elias; SOVERINI, Simona.Seminars in hematology. 2009, Vol 46, Num 2, issn 0037-1963, S22-S26, SUP3Article

Chronic myeloid leukaemiaHEHLMANN, Rüdiger; HOCHHAUS, Andreas; BACCARANI, Michele et al.Lancet (British edition). 2007, Vol 370, Num 9584, pp 342-350, issn 0140-6736, 9 p.Article

Nuclear factor κB as a target for new drug development in myeloid malignanciesCILLONI, Daniela; MARTINELLI, Giovanni; MESSA, Francesca et al.Haematologica (Roma). 2007, Vol 92, Num 9, pp 1224-1229, issn 0390-6078, 6 p.Article

Increased Donor CD86+CD14+ Cells in the Bone Marrow and Peripheral Blood of Patients With Chronic Graft-Versus-Host DiseaseARPINATI, Mario; CHIRUMBOLO, Gabriella; MARZOCCHI, Giulia et al.Transplantation. 2008, Vol 85, Num 12, pp 1826-1832, issn 0041-1337, 7 p.Article

New tyrosine kinase inhibitors in chronic myeloid leukemiaMARTINELLI, Giovanni; SOVERINI, Simona; ROSTI, Gianantonio et al.Haematologica (Roma). 2005, Vol 90, Num 4, pp 534-541, issn 0390-6078, 8 p.Article

Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phaseROSTI, Gianantonio; CASTAGNETTI, Fausto; GUGLIOTTA, Gabriele et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 2, pp 159-170, issn 1040-8428, 12 p.Article

Hypereosinophilic syndrome and molecularly targeted therapyMARTINELLI, Giovanni; RONDONI, Michela; OTTAVIANI, Emanuela et al.Seminars in hematology. 2007, Vol 44, Num 2, issn 0037-1963, S4-S16, SUP2Article

Very elderly patients with essential thrombocythaemia: are they a separate category? A monocentric study on 118 patients older than 75 yearsPALANDRI, Francesca; POLVERELLI, Nicola; CATANI, Lucia et al.British journal of haematology. 2012, Vol 156, Num 5, pp 676-679, issn 0007-1048, 4 p.Article

Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatmentPATRIARCA, Francesca; SILVESTRI, Federico; FANIN, Renato et al.British journal of haematology. 2001, Vol 112, Num 2, pp 370-372, issn 0007-1048Article

First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging StrategiesGUGLIOTTA, Gabriele; CASTAGNETTI, Fausto; APOLINARI, Michela et al.Drugs (Basel). 2014, Vol 74, Num 6, pp 627-643, issn 0012-6667, 17 p.Article

The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance : focus on hematologyCURTI, Antonio; TRABANELLI, Sara; SALVESTRINI, Valentina et al.Blood. 2009, Vol 113, Num 11, pp 2394-2401, issn 0006-4971, 8 p.Article

Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia : evidence of a biclonal derivation and clinical response to autologous stem cell transplantationPATRIARCA, Francesca; GAIDANO, Gianluca; CAPELLO, Daniela et al.Haematologica (Roma). 2000, Vol 85, Num 9, pp 982-985, issn 0390-6078Article

Long-term follow-up of essential thrombocythemia in young adults: treatment strategies, major thrombotic complications and pregnancy outcomes. A study of 76 patientsPALANDRI, Francesca; POLVERELLI, Nicola; OTTAVIANI, Emanuela et al.Haematologica (Roma). 2010, Vol 95, Num 6, pp 1038-1040, issn 0390-6078, 3 p.Article

Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patientsISIDORI, Alessandro; BONIFAZI, Francesca; VISANI, Giuseppe et al.Haematologica (Roma). 2005, Vol 90, Num 1, pp 139-140, issn 0390-6078, 2 p.Article

Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasiaMANDREOLI, Marcora; FINELLI, Carlo; LOPEZ, Antonia et al.American journal of kidney diseases. 2004, Vol 44, Num 4, pp 757-761, issn 0272-6386, 5 p.Article

Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML TherapyKANTARJIAN, Hagop M; BACCARANI, Michele; JABBOUR, Elias et al.Clinical cancer research (Print). 2011, Vol 17, Num 7, pp 1674-1683, issn 1078-0432, 10 p.Article

Diagnosis and management of chronic myeloid leukemia : A survey of american and european practice patternsKANTARJIAN, Hagop M; CORTES, Jorge; GUILHOT, Francois et al.Cancer. 2007, Vol 109, Num 7, pp 1365-1375, issn 0008-543X, 11 p.Article

Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphomaZINZANI, Pier Luigi; ALINARI, Lapo; TANI, Monica et al.Haematologica (Roma). 2005, Vol 90, Num 5, pp 702-703, issn 0390-6078, 2 p.Article

Two more Inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript: clinical and molecular findingsMARTINELLI, Giovanni; OTTAVIANI, Emanuela; BUONAMICI, Silvia et al.Haematologica (Roma). 2002, Vol 87, Num 5, pp 554-555, issn 0390-6078Article